Citation: Df. Silver et Tr. Ashwell, Choices in creating continent urostomies following pelvic exenteration forgynecologic malignancies, GYNECOL ONC, 82(3), 2001, pp. 510-515
Citation: Df. Silver et al., A vaginal and extraperitoneal approach to surgically stage patients with endometrial cancer, GYNECOL ONC, 81(2), 2001, pp. 144-149
Authors:
Silver, DF
Hempling, RE
Piver, MS
Repasky, EA
Citation: Df. Silver et al., Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient mice, GYNECOL ONC, 77(3), 2000, pp. 377-382
Citation: Df. Silver et Ms. Piver, Gemcitabine salvage chemotherapy for patients with gynecologic malignancies of the ovary, fallopian tube, and peritoneum, AM J CL ONC, 22(5), 1999, pp. 450-452
Citation: Df. Silver et Ms. Piver, Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect, GYNECOL ONC, 73(2), 1999, pp. 280-284
Authors:
Silver, DF
Simon, A
Dubin, NH
Wheeless, CR
Citation: Df. Silver et al., Recombinant growth hormone's effects on the strength and thickness of radiation-injured ileal anastomoses: A rat model, J SURG RES, 85(1), 1999, pp. 66-70